infertility & reproductive technologies | Research | 10 pages | source: Archives of Gynecology and Obstetrics | Added Nov 07, 2021
How long should estrogen be supplemented after embryo transfer?
This study evaluated how long estrogen should be used during artificial cycle frozen embryo transfer (FET). It found that stopping estrogen at 6 weeks of pregnancy reduced miscarriages compared to continuing to 12 weeks. Stopping at 6 weeks also led to fewer pregnancy complications.
lung cancer | Research | 10 pages | source: The Lancet. Oncology | Added Nov 07, 2021
Investigating the side effect profiles of different PD-L1/PD-1 inhibitor-based combination therapies.
This study investigated the side effect profiles of different PD-1/PD-L1 inhibitor-based combination therapies. The data showed that PD-1/PD-L1 inhibitors in combination with chemotherapy were associated with a higher risk of treatment-related side effects than with targeted therapy or immunotherapy combinations.
coronary artery disease | Research | Treatment | 7 pages | source: International Journal of Cardiology | Added Nov 06, 2021
Which antithrombotic drug gives more benefit after a heart attack?
This paper reviewed the effectiveness of anti-thrombotic drugs in patients who had a heart attack.
rheumatoid arthritis | Research | Treatment | 10 pages | source: Annals of the rheumatic diseases | Added Nov 06, 2021
After combination treatment: Can methotrexate be stopped?
This study examined stopping methotrexate after 6 months of combined treatment with etanercept. Results showed that continuing combination treatment is preferable to stopping methotrexate.
diabetes mellitus | Research | Treatment | 9 pages | source: Diabetes, Obesity and Metabolism | Added Nov 05, 2021
What dose helps most? Finding the most effective dose for a new type 2 diabetes treatment
This study compared the effectiveness of different dosages of PF-04937319 with sitagliptin and glimepiride in adults with type 2 diabetes being treated with metformin.
rheumatoid arthritis | Research | 10 pages | source: Arthritis Research & Therapy | Added Nov 04, 2021
Adalimumab (Humira) regulates the production of the inflammatory protein TNFalpha
This study examined whether blocking TNFalpha can also regulate the production of TNFalpha in rheumatoid arthritis patients.
lung cancer | Research | Treatment | 9 pages | source: BMC cancer | Added Nov 04, 2021
A pill or a shot? Chemotherapy options for locally advanced non-small cell lung cancer
This study examined the safety and effectiveness of oral vinorelbine (Navelbine), a new form of a standard chemotherapy treatment for stage 3 non-small cell lung cancer.
diabetes mellitus | Research | 10 pages | source: Diabetes & Metabolism | Added Nov 03, 2021
Improved changes in the eye in patients with type 2 diabetes using dapagliflozin compared to glibenclamide.
This study investigated the change in central retinal thickness (CRT) by optical coherence tomography (OCT) in patients with type 2 diabetes (T2D) after 12 weeks of treatment with dapagliflozin (Farxiga) or glibenclamide (Diabeta). The authors concluded that CRT may improve with short-term use of dapagliflozin compared with glibenclamide treatment.
rheumatoid arthritis | Research | Treatment | Guidelines | 12 pages | source: Seminars in Arthritis and Rheumatism | Added Nov 02, 2021
What drug and non-drug based treatments are recommended for osteoarthritis?
This article reviewed guidelines for management of osteoarthritis.
hypertension | Research | Treatment | 10 pages | source: Journal of hypertension | Added Nov 01, 2021
Can air pressure treatment for obstructive sleep apnea reduce blood pressure?
This study examined the effect of continuous positive airway pressure (CPAP) treatment on blood pressure in patients with obstructive sleep apnea. The authors concluded that CPAP treatment resulted in small but significant reductions in blood pressure in patients with obstructive sleep apnea.
